Navigation Links
Researchers Push for Faster Drug Development

As the number of new molecular entities approved by the federal Food and Drug Administration plummets year to year, researchers are scrambling for ways to speed up the laborious drug development process.

Currently it takes about 18 years from the start of target discoveryidentifying a certain enzyme or cell or protein one wants to influenceto introduce a new drug to market. The sheer leng......

Full article >>> working on developing photon-emitting probes that enable observation of a single target molecule, particularly fluorescent and chemically luminescent materialsall because scientists simply arent smart enough to predict how someone will react to a certain chemical, he noted. Therefore, were trying to find a way to go through a large number of compounds to find out what would happen in the human bod......

Full article >>> , said Millis, who received her Ph.D. in biochemistry from UW-Madison. It will first of all hopefully decrease the time from drug identification to a new molecular entity on the market, and it will also increase the probability that the identified compound will actually act as a drug in vivo.

Mattys noted that getting the industry to move on new and faster ways of doing drug discovery may......

Full article >>>
'"/>

Source:wistechnology.com By Lincoln Brunner 11/17/03


Related biology technology :

1. Researchers say scientific reporting needs more perspective, less hype
2. Researchers report development of embryonic stem cells without destroying embryo
3. Researchers report major advance in gene therapy technique
4. Researchers to study fate of prions in wastewater
5. The Learning Game - Researchers Study Video Gaming Principles that Apply to Education
6. Fast Track: FDA User Fees: Do Faster Review Times Justify the Financial Burden?
7. Mission Statement 2003: Do More with Less and Do it Faster!
8. The let-7 microRNA Family Regulates RAS: Implications for Development and Oncogenesis
9. Rapid Method Development With the BioLogic DuoFlow Chromatography System for the Purification of His-Tagged Proteins
10. A Multiple Mutation Model System as a Test Development and Training Tool for Denaturing Gradient Gel Electrophoresis
11. Development of a Multiplex Bead-Based Assay for Antibody Screening of a Nonhuman Primate Colony on the Bio-Plex System
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... 2017 ... share data, unaudited)Three Months Ended December 31,Twelve Months Ended ... $           ... 89026%Aldurazyme Net Product Revenue 3539(10)%9498(4)%Kuvan ... Product Revenue  756025%297303(2)%Vimizim Net Product ...
(Date:2/23/2017)... Feb. 23, 2017  MIODx announced today that ... key immunotherapy technologies from the University of California, ... method to monitor a patient for response to ... CTLA-4.  The second license extends the technology with ... likely to have an immune-related adverse event (IRAE) ...
(Date:2/23/2017)... 23, 2017  Imanis Life Sciences announced today ... oncolytic vaccinia viruses for virotherapy research. These viruses ... Genelux,s proprietary, vaccinia virus-based technology platform for research ... into a partnership with Genelux to offer researchers, ... for use in research," said Dr. Kah ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... 12th annual Inventors Recognition Reception at Purdue Research Park of West ... member in recognition of outstanding contributions to, and success with, commercializing discoveries from ...
Breaking Biology Technology:
(Date:1/26/2017)... Jan. 26, 2017  Acuity Market Intelligence today ... and Digital Identity".  Acuity characterizes 2017 as a ... increased adoption reflects a new understanding of the ... "Biometrics and digital identity are often perceived as ... Most , Principal of Acuity Market intelligence. "However, ...
(Date:1/23/2017)... , Jan. 23, 2017  The latest mobile market ... prices have dropped dramatically. The quarterly average price of ... to $276 in Q4 2016.  There are now 120 ... of $116, up from just 28 a year ago ... According to Maxine Most , Acuity Market Intelligence ...
(Date:1/18/2017)... 2017  In vitro diagnostic (IVD) companies were very ... (M&A), and Kalorama Information expects that trend to continue ... shifting. Generally, uncertainty in reimbursement and healthcare reform in ... changed the acquisitions landscape. Instead of looking to buy ... partners outside of their home country and also to ...
Breaking Biology News(10 mins):